GLP-1 agonists also protect the kidney

GLP-1 agonists also protect the kidney

0 Comments

Sydney – A new comprehensive analysis of the effect of glucagon-like peptide-1 (GLP-1) receptor agonists on renal and cardiovascular outcomes shows they provide significant benefits to people with and without diabetes. As researchers led by

von Graefe Prize 1867-2000

0 Comments

2000 | Prof. Dr. Zrenner 1998 | Prof. Dr. Heimann 1996 | Prof. Dr. Seiler 1994 | Prof. Dr. Bonhoeffer 1992 | Prof. Lütjen-Drecoll 1990 | Prof. Remé 1988 | Prof. Hockwin 1986 | Dr.

New regulations on abortion: 327 MPs...

New regulations on abortion: 327 MPs…

0 Comments

/picture alliance, Jan Woitas Berlin – The cross-party group motion in the Bundestag to revise abortion regulations has already been signed by 327 MPs, according to those supporting it. SPD parliamentary group leader Rolf Mützenich

Treatment-resistant depression: psychodelic psilocybin improves...

Treatment-resistant depression: psychodelic psilocybin improves…

0 Comments

medicine Monday, December 2, 2024 Berlin/Mannheim – Psilocybin improves symptoms in patients with treatment-resistant depression over a week compared to a placebo. However, the therapeutic effect decreases over an observation period of 6 weeks. Lea